Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 15
- Q3 2022, −2 vs. previous quarter
- 13F value
- $110.6K
- Reported value at the end of Q3 2022
- Superinvestors holding
- 0
- At the end of Q3 2022
Superinvestors holding SCPS, Q3 2022
No superinvestor reported holding SCPS at the end of Q3 2022.
Latest insider trades
Open-market purchases and sales by Scopus BioPharma Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +110 | $4.92 | +$541.2 | +0.1%82.5K after | |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +790 | $4.98 | +$3.93K | +5.7%14.6K after | |
| Aug 27, 2021 (view filing) | Aug 26-27 | 1 day | Lamstein Joshua RChairman | PPurchaseCommon Stock, par value $0.001 | +400 | $4.95 | +$1.98K | +0.3%120.0K after | 2 lots |
| Aug 25, 2021 (view filing) | Aug 23-24 | 2 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +550 | $4.43 | +$2.44K | +0.7%82.3K after | 2 lots |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Lamstein Joshua RChairman | PPurchaseCommon Stock, par value $0.001 | +800 | $4.04 | +$3.23K | +0.7%119.6K after | |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +2.00K | $4.04 | +$8.08K | +16.9%13.8K after | |
| Aug 23, 2021 (view filing) | Aug 20 | 3 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +400 | $4.23 | +$1.69K | +0.5%81.8K after | |
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +2.00K | $4.20 | +$8.40K | +20.3%11.8K after | 2 lots |
| Jul 27, 2021 (view filing) | Jul 23-26 | 4 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +2.10K | $4.77 | +$10.0K | +27.1%9.85K after | 2 lots |
| Jul 27, 2021 (view filing) | Jul 26-27 | 1 day | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +600 | $4.69 | +$2.81K | +0.7%81.4K after | 2 lots |
Top 10 13F holders, Q3 2022
The largest institutional positions in Scopus BioPharma Inc. at the end of Q3 2022; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 217,078 | $52.0K | 0.00% | 00.0% | Unchanged |
| M&R Capital Management Inc | 76,819 | $18.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 61,104 | $15.0K | 0.00% | −69,748−53.3% | Reduced |
| Tower Research Capital LLC (TRC) | 26,533 | $6.00K | 0.00% | −1,625−5.8% | Reduced |
| State Street Corp | 20,729 | $5.00K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 14,353 | $3.00K | 0.00% | −43,809−75.3% | Reduced |
| First Manhattan Co | 13,100 | $3.00K | 0.00% | −12,700−49.2% | Reduced |
| Northern Trust Corp | 12,516 | $3.00K | 0.00% | 00.0% | Unchanged |
| Y-Intercept (Hong Kong) Ltd | 10,940 | $2.65K | 0.00% | +10,940 | New |
| JPMorgan Chase & Co | 5,000 | $1.00K | 0.00% | 00.0% | Unchanged |